Intralipid therapy for recurrent implantation failure: New hope or false dawn?

School of Biomedical Sciences, King's College London, Guy's Campus, London SE1 1UL, UK.
Journal of Reproductive Immunology (Impact Factor: 2.82). 12/2011; 93(1):38-40. DOI: 10.1016/j.jri.2011.11.003
Source: PubMed


Recurrent embryo implantation failure (RIF) is a disorder with potentially devastating physiological and psychological manifestations for those affected. Although its prevalence is not uncommon, many of the mechanisms involved still require elucidation. Both organ-specific and systemic autoimmunity are associated with an increased prevalence of recurrent miscarriage and reproductive failure, rendering the role of the maternal immunological system in fertility a key concept. It is believed by some that central to this theme is the maternal cytokine profile, with particularly T-helper (Th) cells. Immune modulating therapies have therefore been mooted as potential therapeutic strategies. Recent reports of high pregnancy rates achievable in women with RIF have added fuel to the debate regarding the effectiveness of intralipid in modulating the immune system. We would like to assess if there is sufficient current evidence of acceptable quality to permit an assumption that intralipid therapy is an effective treatment for women undergoing repeated assisted reproduction cycles. We have concluded that appropriately controlled, large-scale, confirmatory studies are necessary to prove the efficacy of intralipid before it can be recommended for routine use.

137 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Repeated implantation failure (RIF) is determined when embryos of good quality fail to implant following several in vitro fertilization (IVF) treatment cycles. Implantation failure is related to either maternal factors or embryonic causes. Maternal factors include uterine anatomic abnormalities, thrombophilia, non-receptive endometrium and immunological factors. Failure of implantation due to embryonic causes is associated with either genetic abnormalities or other factors intrinsic to the embryo that impair its ability to develop in utero, to hatch and to implant. New methods of time-lapse imaging of embryos and assessment of their metabolic functions may improve selection of embryos for transfer, and subsequent outcomes for IVF patients, as well as for those diagnosed with RIF. This review discusses the various causes associated with RIF and addresses appropriate treatments.
    Journal of Assisted Reproduction and Genetics 09/2012; 29(11). DOI:10.1007/s10815-012-9861-4 · 1.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Local anaesthetic agents are utilised ubiquitously in clinical practice, and as such potentially grave adverse events such as systemic toxicity can occur. Although the use of ultrasound, and nerve stimulator guided administration have reduced the risk of such adversities, they unfortunately have not been eliminated. This review examines the pharmacology and toxicology of local anaesthetic agents and the use of Intravenous Lipid Emulsion (ILE) to counteract the systemic toxic effects. The research underpinning the ‘Lipid Sink’ and ‘Lipid Flux’ theories of ILE mechanism of action are explored, as is the novel and successful use of ILE in other lipophilic drug toxidromes, such as overdoses of tri-cyclic antidepressants and calcium channel antagonists. Also discussed are the potential direct and indirect risks associated with the use of intravenous lipid treatments and the possibility for reporting bias in the literature. Despite this, case reports of the successful use of ILE are certainly compelling, and have led to the rapid adoption of ILE in clinical practice and the recommendation for its use by anaesthetic associations worldwide.
    Trends in Anaesthesia and Critical Care 06/2013; 3(6). DOI:10.1016/j.tacc.2013.04.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: Implantation failure in assisted reproduction is thought to be mainly due to impaired uterine receptivity. With normal uterine anatomy, changes in endocrine profile during ovarian stimulation and medical conditions of the mother (i.e. thrombophilia and abnormal immunological response) could result in a non-receptive endometrium. High oestradiol concentrations during ovarian stimulation lead to premature progesterone elevation, causing endometrial advancement and hampering implantation, which can be overcome by a freeze-all approach and embryo transfer in natural cycles or by milder stimulation protocols. Patients with recurrent implantation failure (RIF) should be tested for inherited and acquired thrombophilias. Each patient should be individually assessed and counselled regarding therapy with low-molecular-weight heparin (LMWH). Empirical treatment with LMWH, aspirin or corticosteroids is not effective for women with RIF who have negative thrombophilic tests. If thrombophilic tests are normal, patients should be tested for immunological causes. If human leukocyte antigen dissimilarity is proven, treatment with intravenous immunoglobulin might be beneficial. Preliminary observational studies using intralipid infusion in the presence of increased natural killer cytotoxic activity are interesting but the proposed rationale is controversial and randomized controlled trials are needed. Hysteroscopy and/ or endometrial scratching in the cycle preceding ovarian stimulation should become standard for patients with RIF.
    Reproductive biomedicine online 06/2013; 27(5). DOI:10.1016/j.rbmo.2013.05.018 · 3.02 Impact Factor
Show more